In brief
A drastic reduction in funding for tuberculosis (TB) programs by the U.S. has left patients in dire straits, particularly in Kenya, where access to life-saving treatments has diminished significantly. Many are suffering and inadvertently spreading the disease, which has seen a troubling spike in cases globally since the cuts.
Dalvin Modore carefully navigated his small farm in western Kenya, his once sturdy frame now frail and vulnerable to the ravages of tuberculosis (TB). At just 40 years old, he struggles under the weight of a severe cough and substantial weight loss—his physical state a reflection of the dire health crisis unfolding across the globe. His plight is not unique; hundreds of thousands of individuals are similarly afflicted, grappling with the harsh reality of lost access to testing and treatment in the aftermath of significant foreign aid cuts announced by the Trump administration. These funding reductions have severely disrupted TB programs that were crucial for identification, care, and treatment methods, particularly in countries in Africa and Asia.In Kenya, the situation has become more precarious due to the cessation of U.S. support, which accounted for nearly half of the international funding directed toward TB initiatives in the previous year. The abrupt withdrawal came on January 20, marking a decisive shift in foreign aid priorities. Local healthcare systems, which relied heavily on U.S. contributions for services from nurse salaries to lab supplies, have seen their operational capabilities diminish, leaving patients without a lifeline.Health officials and advocates are raising alarms about the rising infection rates, with many patients like Modore now endangering the health of their families and communities as they search for treatments that are no longer readily accessible. The Trump administration's stance suggests that an evaluation of foreign aid contracts is underway, prompting a call for other nations to take on a larger role in global health funding.Amid this backdrop, the urgency for solutions grows, as entire healthcare interventions designed to combat TB hang in the balance, with lives hanging by a thread due to a crowding health crisis poised to spiral out of control.
